A new approach to drugging a difficult cancer target
Thursday, March 14, 2019
One of the most common cancer-promoting genes, known as Myc, is also one of the most difficult to target with drugs.
A new approach to drugging a difficult cancer target
One of the most common cancer-promoting genes, known as Myc, is also one of the most difficult to target with drugs.